Valneva Files Registration Statement for Proposed United States Initial Public Offering

Market News

by Webmaster 65 Views

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><br /><p align="justify">Saint-Herblain (France), April 10, 2021 – Valneva SE (the "Company"), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet...

Comments